GHSI Guardion Health Sciences, Inc.

Guardion Health Sciences is at the forefront of early detection, intervention and monitoring of numerous eye diseases that have epidemic or near-epidemic profiles and for which there is substantial market potential for the early diagnosis and treatment.

As of 05/07/2021     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Consumer Staples
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  USA
IPO date:  04/05/2019
Outstanding shares:  24,426,993
Average volume:  626,126
Market cap:   $39,327,459
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    40145Q203
ISIN:        US40145Q2030
Sedol:      BJVSHZ9
Valuation   (See tab for details)
PE ratio:   -4.42
PB ratio:   2.76
PS ratio:   20.81
Return on equity:   -75.52%
Net income %:   -340.26%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy